Literature DB >> 20595295

Anti-RNA polymerase III antibodies as a risk marker for early gastric antral vascular ectasia (GAVE) in systemic sclerosis.

Angela Ceribelli, Ilaria Cavazzana, Paolo Airò, Franco Franceschini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20595295     DOI： 10.3899/jrheum.100124

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  15 in total

1.  Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial.

Authors:  Emily W Hung; Maureen D Mayes; Roozbeh Sharif; Shervin Assassi; Victor I Machicao; Chitra Hosing; E William St Clair; Daniel E Furst; Dinesh Khanna; Stephen Forman; Shin Mineishi; Kristine Phillips; James R Seibold; Christopher Bredeson; Mary Ellen Csuka; Richard A Nash; Mark H Wener; Robert Simms; Karen Ballen; Sharon Leclercq; Jan Storek; Ellen Goldmuntz; Beverly Welch; Lynette Keyes-Elstein; Sharon Castina; Leslie J Crofford; Peter Mcsweeney; Keith M Sullivan
Journal:  J Rheumatol       Date:  2013-02-15       Impact factor: 4.666

2.  Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies.

Authors:  Naomi Serling-Boyd; Melody Pei-Shien Chung; Shufeng Li; Laren Becker; Nielsen Fernandez-Becker; John Clarke; David Fiorentino; Lorinda Chung
Journal:  Semin Arthritis Rheum       Date:  2020-07-06       Impact factor: 5.532

3.  Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.

Authors:  Chenxi Liu; Yong Hou; Dong Xu; Liubing Li; Yanfang Zhang; Linlin Cheng; Songxin Yan; Fengchun Zhang; Yongzhe Li
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

4.  Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.

Authors:  Murray Baron; Janet Pope; David Robinson; Niall Jones; Nader Khalidi; Peter Docherty; Elzbieta Kaminska; Ariel Masetto; Evelyn Sutton; Jean-Pierre Mathieu; Sophie Ligier; Tamara Grodzicky; Sharon LeClercq; Carter Thorne; Geneviève Gyger; Douglas Smith; Paul R Fortin; Maggie Larché; Maysan Abu-Hakima; Tatiana S Rodriguez-Reyna; Antonio R Cabral-Castaneda; Marvin J Fritzler; Mianbo Wang; Marie Hudson
Journal:  Rheumatology (Oxford)       Date:  2016-09-04       Impact factor: 7.580

5.  Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia.

Authors:  Cormac Magee; Gideon Lipman; Durayd Alzoubaidi; Martin Everson; Rami Sweis; Matthew Banks; David Graham; Charles Gordon; Laurence Lovat; Charles Murray; Rehan Haidry
Journal:  United European Gastroenterol J       Date:  2018-11-15       Impact factor: 4.623

Review 6.  Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment.

Authors:  Francesca Dall'Ara; Maria-Grazia Lazzaroni; Chiara M Antonioli; Paolo Airò
Journal:  Rheumatol Int       Date:  2017-02-03       Impact factor: 2.631

7.  Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.

Authors:  Ilaria Cavazzana; Tamara Vojinovic; Paolo Airo'; Micaela Fredi; Angela Ceribelli; Eleonora Pedretti; Maria Grazia Lazzaroni; Emirena Garrafa; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-18       Impact factor: 8.667

Review 8.  Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screen.

Authors:  Maria-Grazia Lazzaroni; Paolo Airò
Journal:  J Scleroderma Relat Disord       Date:  2018-07-13

9.  Gastric antral vascular ectasia in systemic sclerosis.

Authors:  Jill Johnson; Chris T Derk
Journal:  Int J Rheumatol       Date:  2011-11-02

Review 10.  Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review.

Authors:  Mengyuan Peng; Xiaozhong Guo; Fangfang Yi; Fernando Gomes Romeiro; Andrea Mancuso; Xingshun Qi
Journal:  Adv Ther       Date:  2021-09-15       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.